Sunghoon Son, Sokhee P. Jung

Journal of Korean Society of Environmental Engineers • 0

<jats:p>A sediment microbial fuel cell (SMFC) is a system in which MFC is applied to a sediment layer of an aqueous system for water purification. SMFCs can remove contaminants from sediments and decompose organic matter while simultaneously producing electrical energy. SMFC is installed in the form of installing an anode in the sediment at the bottom of the water system and a cathode in the water layer above the sediment, and connecting the two electrodes through an external circuit. Early SMFCs were developed to be used as power sources in hard-to-reach deep water areas or remote areas. However, recently, it has attracted a lot of attention as a technology for biologically purifying pollutants through its own power supply. Furthermore, it is being developed as a means of monitoring the environmental condition of the installed area. Despite the importance of SMFC, no comprehensive review has yet been published to the Korean readers on the trends and prospects of SMFC research. Therefore, in this review paper, the mechanism of SMFC, their mechanism of removal of organic, inorganic, and heavy metals, and the current state of SMFC technology are discussed, and future prospects are presented.</jats:p>

K. Hatake, T. Doi, H. Uetake et al.

Japanese Journal of Clinical Oncology • 2016

BACKGROUND Bevacizumab (Avastin(®)) was approved in Japan in April 2007 for patients with advanced or metastatic colorectal cancer. To address the limited clinical experience in Japanese patients, a post-approval surveillance study was undertaken in bevacizumab-treated patients in Japan. METHODS Bevacizumab (5 or 10 mg/kg every 2 weeks) was administered with chemotherapy; patients were observed for 26 weeks from initiation of treatment. The primary objective was to investigate the incidence of adverse drug reactions, particularly those of interest for bevacizumab. Univariate and multivariate analyses were performed to identify potential risk factors for adverse drug reactions. RESULTS In total, 2712 patients were registered and 2696 patients were included in the safety analysis. Hypertension (13.1%), hemorrhage (10.5%) and proteinuria (4.5%) were the most common adverse drug reaction. The incidences of serious adverse drug reactions were low: gastrointestinal perforation occurred in 0.9% of patients, hemorrhage in 1.3%, arterial thromboembolic events in 0.3%, venous thromboembolic events in 1.3% and wound-healing complications in 0.4%. The incidence of bevacizumab-specific adverse drug reactions was not influenced by the bevacizumab dose. Multivariate analyses identified risk factors for the following adverse drug reactions: hypertension (prior/concurrent hypertension); tumor-associated bleeding (performance status, prior/concomitant anticoagulant or nonsteroidal anti-inflammatory drug use); proteinuria (sex, performance status, prior/concurrent diabetes and proteinuria); gastrointestinal perforation (primary tumor in situ, concurrent nonsteroidal anti-inflammatory drug use); venous thromboembolic event (treatment stage, port insertion). CONCLUSIONS The safety profile of bevacizumab-containing regimens in this Japanese population was comparable with studies performed in Western countries. Bevacizumab is generally well tolerated in Japanese patients with advanced or metastatic colorectal cancer.

A. Inoue, K. Yoshida, S. Morita et al.

Japanese Journal of Clinical Oncology • 2016

Background The Japan Guidelines of Lung Cancer Therapy recommend epidermal growth factor receptor-tyrosine kinase inhibitors as a first-line therapy for advanced/recurrent non-small cell lung cancer patients with epidermal growth factor receptor mutation. Although survival periods in recent reports of epidermal growth factor receptor-tyrosine kinase inhibitor treatment have been getting longer, the reasons why are unclear. We investigated the survival, prognostic factors and real-world treatment of non-small cell lung cancer patients with epidermal growth factor receptor mutation in clinical practice. Methods Non-small cell lung cancer patients (n = 1660) who started first-line treatment from January 2008 to December 2012 were enrolled. Patients were diagnosed with epidermal growth factor receptor mutation-positive advanced/recurrent non-small cell lung cancer by histology or cytology samples. The primary objective was to estimate overall survival. The secondary objectives were to determine prognostic factors, real-world treatment patterns and efficacy of gefitinib treatment. We calculated the treatment exposure rate for each treatment category using the following formula: exposure rate = person-years for the treatment category/total person-years × 100. Results The median overall survival was 30.8 months. Sex, age, histology, epidermal growth factor receptor mutation type, clinical stage and performance status affected overall survival. The exposure rates for all epidermal growth factor receptor-tyrosine kinase inhibitors, gefitinib and platinum-doublet chemotherapy were 62.1, 46.4 and 8.5% respectively. Overall 56.1% of patients were administered gefitinib as first-line therapy, and 39.0% were treated with ≥2 epidermal growth factor receptor-tyrosine kinase inhibitor regimens. The median progression-free survival in the first-line gefitinib group was 11.4 months. Factors affecting prognosis were sex, histology, clinical stage and performance status. Conclusion Epidermal growth factor receptor-tyrosine kinase inhibitors, especially gefitinib, are major components of the treatment regimens for epidermal growth factor receptor mutation-positive non-small cell lung cancer. Switching and re-challenging with epidermal growth factor receptor-tyrosine kinase inhibitors were also practiced in Japan.

Naoya Miyashita, Y. Yamauchi

Japanese Clinical Medicine • 2018

Bacterial pneumonia is one of the most important infectious diseases in terms of incidence, effect on quality of life, mortality, and impact on society. Pneumonia was the third leading cause of death in Japan in 2011. In 2016, 119 650 Japanese people died of pneumonia, 96% of whom were aged 65 years and above. The symptoms of pneumonia in elderly people are often atypical. Aspiration pneumonia is seen more frequently than in young people because of swallowing dysfunction in the elderly. The mortality rate is also higher in the elderly than in young people. In Japan, the population is aging at an unprecedented rate, and pneumonia in the elderly will be increasingly important in medicine and medical economics in the future. To manage pneumonia in the elderly, it is important to accurately evaluate its severity, administer appropriate antibiotic treatment, and implement effective preventive measures.

K. Cameron

• 2016

The purpose of this paper is to present a brief background of tribal reservations, the process of how Microbial Fuel Cells (MFCs) work, and the potential benefits of using MFCs on tribal reservations to convert waste water to energy as a means to sustainably generate electricity. There have been no known studies conducted on tribal lands that would be able to add to the estimated percentage of all renewable energy resources identified. Not only does MFC technology provide a compelling, innovative solution, it could also address better management of wastewater, using it as a form of energy generation. Using wastewater for clean energy generation could provide a viable addition to community infrastructure systems improvements.

S. Sambavi, S. Vishali, Sunita Varjani et al.

Indian Journal of Experimental Biology • 2020

Rapid industrialization and population growth have generated a worldwide interest in renewable energy resourcesto meet. In this context, microbial fuel cells serve the dual purpose of electricity generation and wastewater treatment in a sustainable way. Here, we conducted a set of experiments in two-chambered microbial fuel cell (MFC) to study its efficiency in chemical oxygen demand (COD) removal and electricity generation. The MFC was run at constant pH of 5.5 and mesophilic temperature of 30-32  C using mixed consortia of sediment as inoculum and candy industry wastewater as substrate. Of the five different initial substrate concentrations of 2000, 4000, 6000, 8000 and 10000 mg COD/L studied, the highest COD removal efficiency of 96.0% and electricity generation of 810 mV was recorded at the initial substrate concentration of 4000 mg COD/L. The experiments conducted also revealed that iron oxide nanoparticles concentration of 0.10 g/L with an average size of 25.64 nm, increased the electricity generation potential to 870 mV by 6.9%. Among the different species of bioelectricity generating bacteria colonized, Corynebacterium variabile SMS-14 was documented as the most dominant species.

Erdan Luo, Daiyan Zhang, Hua Luo et al.

Chinese Medicine • 2020

Background A novel coronavirus was identified in December, 2019 in Wuhan, China, and traditional Chinese medicine (TCM) played an active role in combating the novel coronavirus pneumonia (NCP) caused by this fast-spreading virus COVID-19. Thus, we aimed to explore TCM characteristics of clinical efficacy to NCP, as well as to optimize Qingfei Paidu decoction (QFPDD) and the recommended formulas to NCP by National Health Commission (NHC). Methods Chinese medical sciences theory and clinical application of TCM were analyzed. A total of 54 NCP patients were observed in a hospital from Wuhan, whose clinical characteristics and utilization of Chinese Medicines (CMs) were described. Paired t test was used to measure the change of patients’ hemogram during hospitalization period, indicating the effect of CMs. Multiple linear regression analysis was applied to explore the factors affecting the length of hospital stay. Network pharmacology analysis was applied to figure out the performance of NHC-recommended formulas of five disease stages at levels of compounds, targets and pathways. Result The average length of hospital stay was 8.96 days. Patients over 45 stayed 9.79 days in hospital in average, longer than 7.64 days of patients under 45. Comparing the hemograms between admission and discharge of hospital, the number of leukocytes, neutrophil, lymphocyte and platelet increased, while the numbers of erythrocytes, hemoglobin concentration and hematocrit decreased. According to the standard coefficients of regression, the factor affecting the length of stay for the most was CMs in category of invigorating spleen and removing dampness (ISRD), followed by administrating CMs, male, and cough. Thirty-two CMs were screened after deleting duplication from QFPDD and NHC-recommended formulas. Compound quercetin, luteolin, kaempferol, acacetin etc., were all involved in the treatment of various disease stages on the compound level both in generality and individuality. Conclusion TCM has a systemic theoretical understanding on the pathological evolution and a positive clinical efficacy on NCP. The CMs of ISRD improved patients’ recovery, suggesting the importance of regulating intestinal function and keeping microenvironmental balance in TCM treatment of NCP. The active compounds from QFPDD and NHC-recommended formulas contribute to recovery of varied disease progresses during TCM treating NCP.

J. Plantin, G. de Seta

Chinese Journal of Communication • 2019

In the current research on media and communication, Western internet companies (e.g. Google and Facebook) are typically described as digital platforms, yet these actors increasingly rely on infrastructural properties to expand and maintain their market power. Through the case study of the Chinese social media application, WeChat, we argue that WeChat is an example of a non-Western digital media service that owes its success first to its platformization and then to the infrastructuralization of its platform model. Moreover, our findings show that the infrastructuralization of the WeChat platform model in China is shaped by markedly techno-nationalist media regulations and an increasingly overt cyber-sovereignty agenda. Drawing on the results of the analysis of technical documentation, business reports, as well as observations and interviews, we first present WeChat as both a platform and an infrastructure, and then we contextualize WeChat in the history of ICT infrastructure and the development of the internet in China. Finally, we analyze the specific role of the WeChat Pay service in establishing a new monetary transaction standard. We conclude by inquiring whether this emerging techno-nationalist model could be a plausible platform regulation in the future.

Xu Chen, D. B. V. Kaye, Jing Zeng

Chinese Journal of Communication • 2020

In Chinese political discourse, “positive energy” (zheng nengliang) is a popular expression that has embodied mainstream political ideology in China since 2012. This term has also become prominent on Douyin, a prominent Chinese short-video platform. By June 2018, over 500 Chinese governmental accounts on Douyin had promoted positive energy in videos, and the content was viewed over 1.6 billion times. Douyin even created a separate trending section, Positive Energy, for videos that promoted the dominant state ideology. This study argues that the Positive Energy feature on Douyin is significant. The Chinese government has accused and even permanently shut down several digital platforms for spreading “vulgarity” as the antithesis of positive energy. Using the app walkthrough method and a content analysis of over 800 videos collected from the Positive Energy section of Douyin, this study explores how Douyin promotes the Chinese state’s political agenda by promoting a new form of playful patriotism online.

Sumei Wang, Shunqin Long, Zhiyin Deng et al.

The American Journal of Chinese Medicine • 2020

Complementary and alternative medicine (CAM) plays a critical role in treating cancer patients. Traditional Chinese Medicine (TCM) is the main component of CAM. TCM, especially Chinese Herbal Medicine (CHM), has been increasingly used in China, some other Asian countries and European countries. It has been proven to enhance the efficacy of chemotherapy, radiotherapy, targeted-therapy, and immunotherapy. It lessens the damage caused by these therapies. CHM functions on cancer by inhibiting tumor progression and improving an organism's immune system. Increasing evidence has shown that many CHM exert favorable effects on the immune regulation. We will summarize the role of CHM on patient's immune system when treating cancer patients. Our evidence reveals that single herbs, including their extracts, compound formulations, and preparations, will provide current advances on CHM study, especially from the perspective of immune regulation and novel insights for CHM application in clinic. The main herbs used to treat cancer patients are health-strengthening (Fu-Zheng) herbs and pathogen eliminating (Qu-Xie) herbs. The key mechanism is regulating the immune system of cancer patients. Firstly, health-strengthening herbs are mainly functioned as immune regulatory effectors on cancer. Secondly, some of the compound formulations mainly strengthen the health of patients by regulating the immune system of cancer patients. Lastly, some Chinese medicine preparations are widely used to treat cancer for their properties of spiriting vital energy and anti-cancer effects, mainly by improving immunity. CHM plays a positive role in regulating patients' immune system, which helps cancer patients to fight against cancer itself and finally improves patients' life quality.

Yulin Wang, Xiuming Shi, Li Li et al.

The American Journal of Chinese Medicine • 2021

Traditional Chinese Medicine (TCM) is a well-established medical system with a long history. Currently, artificial intelligence (AI) is rapidly expanding in many fields including TCM. AI will significantly improve the reliability and accuracy of diagnostics, thus increasing the use of effective therapeutic methods for patients. This systematic review provides an updated overview on the major breakthroughs in the field of AI-assisted TCM four diagnostic methods, syndrome differentiation, and treatment. AI-assisted TCM diagnosis is mainly based on digital data collected by modern electronic instruments, which makes TCM diagnosis more quantitative, objective, and standardized. As a result, the diagnosis decisions made by different TCM doctors exhibit more consistency, accuracy, and reliability. Meanwhile, the therapeutic efficacy of TCM can be evaluated objectively. Therefore, AI is promoting TCM from experience to evidence-based medicine, a genuine scientific revolution. Furthermore, huge and non-uniform knowledge on formula-syndrome relationships and the combination rules of herbal TCM formulae could be better standardized with the help of AI analysis, which is necessary for the clinical efficacy evaluation and further optimization on the standardized TCM formulae. AI bridges the gap between TCM and modern science and technology. AI may bring clinical TCM diagnostics closer to western medicine. With the help of AI, more scientific evidence about TCM will be discovered. It can be expected that more unified guidelines for specific TCM syndromes will be issued with the development of AI-assisted TCM therapies in the future.

Huajuan Jiang, Minmin Li, Kequn Du et al.

Chinese Medicine • 2021

The high incidence of breast cancer is the greastest threat to women’ health all over the world. Among them, HER-2 positive breast cancer has the characteristics of high malignancy, easy recurrence and metastasis, and poor prognosis. Traditional Chinese medicine (TCM) has a rich theoretical basis and clinical application for breast cancer. TCM believes that blood stasis syndrome is one of the important pathogenesis of breast formation and development. Taohong Siwu Decoction (TSHWD) is based on the “First Prescription of Gynecology” Siwu Decoction. It is widely used in various blood stasis and blood deficiency syndromes, mainly in gynecological blood stasis. Clinical studies have found that THSWD can treat breast cancer by reducing blood vessel and lymphangiogenesis with auxiliary chemotherapy. In this study, we aim to explore the material basis and mechanism of THSWD in the treatment of HER-2 positive breast cancer through literature review and network pharmacology studies. Through a literature review of the traditional application, chemical composition of Chinese herbal medicine of THSWD, as well as its clinical reports and pharmacological research on breast cancer treatment. Meanwhile, we conducted “component-pathway-target” network through network pharmacology reveals the main material basis, possible targets and pathways of THSWD in inhibiting HER-2 positive breast cancer. Literature review and network pharmacology research results had predicted that, baicalein, kaempferol, caffeic acid, amygdalin, quercetin, ferulic acid, gallic acid, catalpol, hydroxysafflor yellow A, paeoniflorin in THSWD are the main effective chemical composition. THSWD regulates 386 protein targets and 166 pathways related to breast cancer. The molecular mechanism is mainly to improve the microenvironment of tumor cells, regulate the process of tumor cell EMT, and inhibit tumor cell proliferation and metastasis. This study revealed the mechanism of action of THSWD in the treatment of HER-2 positive breast cancer through literature review and network pharmacology studies, providing a scientific basis for clinical application.

Shuo Yuan, Qi Wang, Jiao Li et al.

Chinese Medicine • 2022

Inflammatory bowel disease (IBD) is a chronic recurrent inflammatory disease of the intestine, including Crohn’s disease (CD) and ulcerative colitis (UC), whose etiology and pathogenesis have not been fully understood. Due to its prolonged course and chronic recurrence, IBD imposes a heavy economic burden and psychological stress on patients. Traditional Chinese Herbal Medicine has unique advantages in IBD treatment because of its symptomatic treatment. However, the advantages of the Chinese Herbal Medicine Formula (CHMF) have rarely been discussed. In recent years, many scholars have conducted fundamental studies on CHMF to delay IBD from different perspectives and found that CHMF may help maintain intestinal integrity, reduce inflammation, and decrease oxidative stress, thus playing a positive role in the treatment of IBD. Therefore, this review focuses on the mechanisms associated with CHMF in IBD treatment. CHMF has apparent advantages. In addition to the exact composition and controlled quality of modern drugs, it also has multi-component and multi-target synergistic effects. CHMF has good prospects in the treatment of IBD, but its multi-agent composition and wide range of targets exacerbate the difficulty of studying its treatment of IBD. Future research on CHMF-related mechanisms is needed to achieve better efficacy.

Xuan Zhang, Lin Zhang, Jacky C. P. Chan et al.

Chinese Medicine • 2022

Objective To investigate how the ulcerative colitis (UC) be treated with Chinese herbal medicines (CHM), using Chinese medicine (CM) pattern ( zheng ) identification, in the current clinical practice. Methods A total of 7 electronic databases were systematically searched for UC clinical studies with CHM interventions (including single herbs and CHM formulas) published in English and Chinese from the date of their inception to November 25, 2020. Descriptive statistics were adopted to demonstrate the characteristics of study design, and to collate the commonly CM patterns of UC and frequently used CHM herbs and formulas. Further, IBM SPSS Modeler 18.0 and Cytoscape 3.7.1 software were used to analyze and visualize the associations between different categories of CHM and their zheng indications. Results A total of 2311 articles were included in this study, of which most (> 90%) were RCTs with CHM formulas. The most common zheng of UC was Large intestine dampness-heat , while the basic type of CM patten was Spleen deficiency . The most frequently used classical formula was Bai-Tou-Weng-Tang , followed by Shen-Ling-Bai-Zhu-San , and the commonly used proprietary CHM was Xi-Lei-San (enema). Sulfasalazine and Mesalazine are commonly used as concomitant western medicines. The most frequently used single medicinals were Huang Lian and Bai Zhu , which also identified as the core herbs for different CM patterns. Conclusion This study examined the application of CHM interventions for UC and summarized their characteristics in clinical practice. These data indicated there were limited information about the safety assessment of CHM formulas and further RCTs including CM pattern(s) with strict design are necessary.

Xiaojuan Liu, Xiangka Hu, He Yang et al.

The American Journal of Chinese Medicine • 2022

Diabetic nephropathy (DN) is a common microvascular complication of diabetes mellitus (DM), which can lead to renal failure in diabetic patients. At present, the first-line drugs for DN are mainly the renin-angiotensin system (RAS) inhibitors or angiotensin receptor blockers, and the latest approved aldosterone receptor antagonist finerenone, which delay the progression of DN to end-stage renal disease (ESRD), but the therapeutic effect is still not ideal. With a history of thousands of years, traditional Chinese medicine (TCM) has rich experience in the treatment of DN. Based on the theory of TCM, the clinical treatment of DN mainly focuses on generating fluid and nourishing blood, nourishing Qi and Yin, detoxifying and detumescent. In recently years, the therapeutic effects and mechanisms of TCM prescription, Chinese herbal medicine, and its active components on DN have received extensive attention in new drug development. This paper reviews the research progress of the mechanism of TCM on DN.

Hui-qin Luo, Qiao-ling Tang, Ya-xi Shang et al.

Chinese Journal of Integrative Medicine • 2020

Objective Since December 2019, an outbreak of corona virus disease 2019 (COVID-19) occurred in Wuhan, and rapidly spread to almost all parts of China. This was followed by prevention programs recommending Chinese medicine (CM) for the prevention. In order to provide evidence for CM recommendations, we reviewed ancient classics and human studies. Methods Historical records on prevention and treatment of infections in CM classics, clinical evidence of CM on the prevention of severe acute respiratory syndrome (SARS) and H1N1 influenza, and CM prevention programs issued by health authorities in China since the COVID-19 outbreak were retrieved from different databases and websites till 12 February, 2020. Research evidence included data from clinical trials, cohort or other population studies using CM for preventing contagious respiratory virus diseases. Results The use of CM to prevent epidemics of infectious diseases was traced back to ancient Chinese practice cited in Huangdi’s Internal Classic (Huang Di Nei Jing) where preventive effects were recorded. There were 3 studies using CM for prevention of SARS and 4 studies for H1N1 influenza. None of the participants who took CM contracted SARS in the 3 studies. The infection rate of H1N1 influenza in the CM group was significantly lower than the non-CM group (relative risk 0.36, 95% confidence interval 0.24–0.52; n=4). For prevention of COVID-19, 23 provinces in China issued CM programs. The main principles of CM use were to tonify qi to protect from external pathogens, disperse wind and discharge heat, and resolve dampness. The most frequently used herbs included Radix astragali (Huangqi), Radix glycyrrhizae (Gancao), Radix saposhnikoviae (Fangfeng), Rhizoma Atractylodis Macrocephalae (Baizhu), Lonicerae Japonicae Flos (Jinyinhua), and Fructus forsythia (Lianqiao). Conclusions Based on historical records and human evidence of SARS and H1N1 influenza prevention, Chinese herbal formula could be an alternative approach for prevention of COVID-19 in high-risk population. Prospective, rigorous population studies are warranted to confirm the potential preventive effect of CM.

S. Zheng, Tianyu Xue, Bin Wang et al.

The American Journal of Chinese Medicine • 2022

Ulcerative colitis (UC) is a common clinical inflammatory bowel disease characterized by repeated attacks, difficult treatment, and great harm to the physical and mental health of the patients. The occurrence and development of UC were closely related to the physiological and pathological processes, such as intestinal inflammatory reaction, oxidizing reaction, and immune response. Treatment of ulcerative colitis using Western medicine is often associated with a number of limitations and adverse events. There is a long history of using traditional Chinese medicine in dealing with this medical condition. Commonly used traditional Chinese medicines for the treatment of UC include Caulis Sargentodoxae, Flos Lonicerae, Fructus Cnidii, etc. Additionally, classic prescriptions such as Gegen Qinlian Formulae and Zuojin Pills can also be used to treat UC. To enrich the traditional Chinese medicine theory, the cognitive theory and perspective of network pharmacology and bioinformatics research of cell signal transduction mechanism of UC are emerging rapidly. Modern pharmacological studies focus on underlying mechanisms for the management of UC with Chinese medicine monomers, single Chinese medicines, and traditional Chinese medicine formulations, alleviating the symptoms of UC, controlling the development of intestinal inflammation, and restoring intestinal function through the regulation of key molecular signaling pathways, including PI3K/Akt, NF-[Formula: see text]B, JAK/STAT, MAPK and Notch. By summarizing current research progressions, this review provides key references for the in-depth exploration of the mechanisms focused on signaling pathways for the clinical management of UC using traditional Chinese medicine.

Li-Yang Zhou, Hong Lu, Zhiqiang Song et al.

Chinese Medical Journal • 2022

Abstract Background: Helicobacter pylori (H. pylori) infection is an infectious disease with a prevalence rate of up to 50% worldwide. It can cause indigestion, gastritis, peptic ulcer, and gastric cancer. H. pylori eradication treatment can effectively control disease progression and reduce the risk of the above conditions. However, the escalating trend of antibiotic resistance presents a global challenge for H. pylori eradication. We aim to provide guidance on pharmacological treatment of H. pylori infection. Methods: This clinical practice guideline is developed following the World Health Organization's recommended process, adopting Grading of Recommendations Assessment, Development and Evaluation in assessing evidence quality, and utilizing Evidence to Decision framework to formulate clinical recommendations, minimizing bias and increasing transparency of the clinical practice guideline development process. We used the Reporting Items for practice Guidelines in HealThcare (RIGHT) statement and The Appraisal of Guidelines for Research and Evaluation II (AGREE II) as reporting and conduct guides to ensure the guideline's completeness and transparency. Results: Though decreasing in developed countries, the prevalence of H. pylori remains high in developing countries, causing a major public health burden. This clinical practice guideline contains 12 recommendations concerning pharmacological treatment for H. pylori eradication. Among them, it is worth highlighting that bismuth preparations are inexpensive, safe, and effective, consequently making bismuth quadruple therapy a preferred choice for initial and rescue treatment. In empirical treatment, high-dose dual therapy is equally effective compared with bismuth quadruple therapy. Conclusions: The 12 recommendations in this clinical practice guideline are formed with consideration for stakeholders’ values and preferences, resource use, feasibility, and acceptability. Recommendations are generalizable to resource limited settings with similar antibiotic resistance pattern as China, and lower middle-income countries facing comparable sociological and technical challenges. Registration: Guidelines International Network (GIN) website, https://guidelines.ebmportal.com/node/69996.

Xianglong Meng, Xiaoqing Liu, Jiaying Tan et al.

Chinese Medicine • 2023

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia resulting from insulin secretion defects or insulin resistance. The global incidence of DM has been gradually increasing due to improvements in living standards and changes in dietary habits, making it a major non-communicable disease that poses a significant threat to human health and life. The pathogenesis of DM remains incompletely understood till now, and current pharmacotherapeutic interventions are largely inadequate, resulting in relapses and severe adverse reactions. Although DM is not explicitly mentioned in traditional Chinese medicine (TCM) theory and clinical practice, it is often classified as “Xiaoke” due to similarities in etiology, pathogenesis, and symptoms. With its overall regulation, multiple targets, and personalized medication approach, TCM treatment can effectively alleviate the clinical manifestations of DM and prevent or treat its complications. Furthermore, TCM exhibits desirable therapeutic effects with minimal side effects and a favorable safety profile. This paper provides a comprehensive comparison and contrast of Xiaoke and DM by examining the involvement of TCM in their etiology, pathogenesis, treatment guidelines, and other relevant aspects based on classical literature and research reports. The current TCM experimental research on the treatment of DM by lowering blood glucose levels also be generalized. This innovative focus not only illuminates the role of TCM in DM treatment, but also underscores the potential of TCM in DM management.

Ling Li, Lele Yang, Liuqing Yang et al.

Chinese Medicine • 2023

Network pharmacology can ascertain the therapeutic mechanism of drugs for treating diseases at the level of biological targets and pathways. The effective mechanism study of traditional Chinese medicine (TCM) characterized by multi-component, multi-targeted, and integrative efficacy, perfectly corresponds to the application of network pharmacology. Currently, network pharmacology has been widely utilized to clarify the mechanism of the physiological activity of TCM. In this review, we comprehensively summarize the application of network pharmacology in TCM to reveal its potential of verifying the phenotype and underlying causes of diseases, realizing the personalized and accurate application of TCM. We searched the literature using “TCM network pharmacology” and “network pharmacology” as keywords from Web of Science, PubMed, Google Scholar, as well as Chinese National Knowledge Infrastructure in the last decade. The origins, development, and application of network pharmacology are closely correlated with the study of TCM which has been applied in China for thousands of years. Network pharmacology and TCM have the same core idea and promote each other. A well-defined research strategy for network pharmacology has been utilized in several aspects of TCM research, including the elucidation of the biological basis of diseases and syndromes, the prediction of TCM targets, the screening of TCM active compounds, and the decipherment of mechanisms of TCM in treating diseases. However, several factors limit its application, such as the selection of databases and algorithms, the unstable quality of the research results, and the lack of standardization. This review aims to provide references and ideas for the research of TCM and to encourage the personalized and precise use of Chinese medicine.

Ilham Mufandi, Isti Nur Azizah, A. Efendi et al.

CHEMICA: Jurnal Teknik Kimia • 2018

The vegetable waste is one of the biomass types that it can produce electrical energy.  This article focused on electrical production of vegetable waste using microbial fuel cells (MFCS) MFCs is the primary type of the bioelectrochemical system (BECs) that to replaces the biomass to electrical energy spontaneously by activity metabolism of the microorganism. The objectives of this work were to investigate the process of electrical production from Chinese cabbage and the combination of the materials to produce the electrical energy. The experiment was carried out in a laboratory-sall such as mini reactor MFCs, Chinese cabbage as the material of vegetable waste and EM4 as the fermentation. Sample combination was consist of two parts that the first part was used 1 kg Chinese cabbage, 2 liter water and 20 ml EM4. The second part was used 2 kg Chinese cabbage, 1 liter water and 20 ml EM4. The result showed that the electrical voltage in part 1 at 0.362 V and pH at 6 was lower than the electrical voltage in part 2 at 0.724 V and pH at 7. Declining electric energy is influenced by pH as microorganisms living place and the formation process of attached media at the electrode.

Lihua Zhou, Lihua Sun, P. Fu et al.

Journal of Materials Chemistry A • 2017

Three-dimensional (3D) electrodes have been intensively investigated as high-performance electrodes to harvest microbial energy in bioelectrochemical systems (BESs). However, the fabrication of low-cost high-performance 3D electrodes is still a great challenge. Herein, we reported a new highly conductive and biocompatible 3D electrode by simply coating natural loofah sponge (LS) with low-cost Chinese ink (CI) that has been used for writing and drawing for thousands of years. A high current density of 16.3 ± 0.5 mA cm−3 was achieved by the as-prepared Chinese ink-coated loofah sponge (CI-LS), which is close to that of the 3D electrode produced from the carbonized LS and equals those of most of the available materials in the current state of research. This high current density is attributed to the open macroporous structure of the LS as well as high conductivity and good biocompatibility of the carbon nanoparticle coating layers. The performance of the CI-LS depended strongly on the type of CI used as the conductive coating material. Besides, the resulting bioelectrode displayed promising stability, which outperformed other 3D electrodes based on synthetic sponges. Considering the low-cost and facile fabrication, this CI-LS 3D electrode has promising potential for high-performance and cost-effective BESs on a large scale.

Qian Ding, Yingxiu Cao, Feng Li et al.

• 2021

Microbial fuel cell (MFC) is a bioelectrochemical device, that enables simultaneous wastewater treatment and energy generation. However, a few issues such as low output power, high ohmic internal resistance, and long start-up time greatly limit MFCs' applications. MFC anode is the carrier of microbial attachment, and plays a key role in the generation and transmission of electrons. High-quality bioelectrodes have developed into an effective way to improve MFC performance. Conjugated polymers have advantages of low cost, high conductivity, chemical stability and good biocompatibility. The use of conjugated polymers to modify bioelectrodes can achieve a large specific surface area and shorten the charge transfer path, thereby achieving efficient biological electrochemical performance. In addition, bacteria can be coated with nano-scale conjugated polymer and effectively transfer the electrons generated by cells to electrodes. This article reviews the recently reported applications of conjugated polymers in microbial fuel cells, focusing on the MFC anode materials modified by conjugated polymers. This review also systematically analyzes the advantages and limitations of conjugated polymers, and how these composite hybrid bioelectrodes solve practical issues such as low energy output, high inner resistance, and long starting time.

Guangle Li, Xiyun Feng, Jinbo Fei et al.

Advanced Materials Interfaces • 2017

<jats:p>A biohybrid photoanode is constructed by integrating photosystem II with doped conducting polymer nanowires that are synthesized by template‐directed electrochemical deposition. Interestingly, at the same applied bias potential ranging from 0 to 0.5 V versus saturated calomel electrode (SCE), this hybrid photoanode shows a higher photocurrent than that of pure photosystem II coated on a bare indium tin oxide (ITO) surface. Particularly, the photocurrent for the integrated photoanode above is enhanced about 39.0‐fold with increased stability (0.25 V vs SCE). Such assembled system combining natural photoactive protein with artificial low‐cost conducting polymer shows great potential for advanced solar energy conversion.</jats:p>

A. Timmis, N. Townsend, C. Gale et al.

European Heart Journal • 2019

AIMS The 2019 report from the European Society of Cardiology (ESC) Atlas provides a contemporary analysis of cardiovascular disease (CVD) statistics across 56 member countries, with particular emphasis on international inequalities in disease burden and healthcare delivery together with estimates of progress towards meeting 2025 World Health Organization (WHO) non-communicable disease targets. METHODS AND RESULTS In this report, contemporary CVD statistics are presented for member countries of the ESC. The statistics are drawn from the ESC Atlas which is a repository of CVD data from a variety of sources including the WHO, the Institute for Health Metrics and Evaluation, and the World Bank. The Atlas also includes novel ESC sponsored data on human and capital infrastructure and cardiovascular healthcare delivery obtained by annual survey of the national societies of ESC member countries. Across ESC member countries, the prevalence of obesity (body mass index ≥30 kg/m2) and diabetes has increased two- to three-fold during the last 30 years making the WHO 2025 target to halt rises in these risk factors unlikely to be achieved. More encouraging have been variable declines in hypertension, smoking, and alcohol consumption but on current trends only the reduction in smoking from 28% to 21% during the last 20 years appears sufficient for the WHO target to be achieved. The median age-standardized prevalence of major risk factors was higher in middle-income compared with high-income ESC member countries for hypertension {23.8% [interquartile range (IQR) 22.5-23.1%] vs. 15.7% (IQR 14.5-21.1%)}, diabetes [7.7% (IQR 7.1-10.1%) vs. 5.6% (IQR 4.8-7.0%)], and among males smoking [43.8% (IQR 37.4-48.0%) vs. 26.0% (IQR 20.9-31.7%)] although among females smoking was less common in middle-income countries [8.7% (IQR 3.0-10.8) vs. 16.7% (IQR 13.9-19.7%)]. There were associated inequalities in disease burden with disability-adjusted life years per 100 000 people due to CVD over three times as high in middle-income [7160 (IQR 5655-8115)] compared with high-income [2235 (IQR 1896-3602)] countries. Cardiovascular disease mortality was also higher in middle-income countries where it accounted for a greater proportion of potential years of life lost compared with high-income countries in both females (43% vs. 28%) and males (39% vs. 28%). Despite the inequalities in disease burden across ESC member countries, survey data from the National Cardiac Societies of the ESC showed that middle-income member countries remain severely under-resourced compared with high-income countries in terms of cardiological person-power and technological infrastructure. Under-resourcing in middle-income countries is associated with a severe procedural deficit compared with high-income countries in terms of coronary intervention, device implantation and cardiac surgical procedures. CONCLUSION A seemingly inexorable rise in the prevalence of obesity and diabetes currently provides the greatest challenge to achieving further reductions in CVD burden across ESC member countries. Additional challenges are provided by inequalities in disease burden that now require intensification of policy initiatives in order to reduce population risk and prioritize cardiovascular healthcare delivery, particularly in the middle-income countries of the ESC where need is greatest.

J. Dawson, Y. Béjot, L. Christensen et al.

European Stroke Journal • 2022

Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke Organisation (ESO) guideline provides evidence-based recommendations on pharmacological management of blood pressure (BP), diabetes mellitus, lipid levels and antiplatelet therapy for the prevention of recurrent stroke and other important outcomes in people with ischaemic stroke or transient ischaemic attack (TIA). It does not cover interventions for specific causes of stroke, including anticoagulation for cardioembolic stroke, which are addressed in other guidelines. This guideline was developed through ESO standard operating procedures and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. The working group identified clinical questions, selected outcomes, performed systematic reviews, with meta-analyses where appropriate, and made evidence-based recommendations, with expert consensus statements where evidence was insufficient to support a recommendation. To reduce the long-term risk of recurrent stroke or other important outcomes after ischaemic stroke or TIA, we recommend: BP lowering treatment to a target of <130/80 mmHg, except in subgroups at increased risk of harm; HMGCoA-reductase inhibitors (statins) and targeting a low density lipoprotein level of <1.8 mmol/l (70 mg/dl); avoidance of dual antiplatelet therapy with aspirin and clopidogrel after the first 90 days; to not give direct oral anticoagulant drugs (DOACs) for embolic stroke of undetermined source and to consider pioglitazone in people with diabetes or insulin resistance, after careful consideration of potential risks. In addition to the evidence-based recommendations, all or the majority of working group members supported: out-of-office BP monitoring; use of combination treatment for BP control; consideration of ezetimibe or PCSK9 inhibitors when lipid targets are not achieved; consideration of use of low-dose DOACs in addition to an antiplatelet in selected groups of people with coronary or peripheral artery disease and aiming for an HbA1c level of <53 mmol/mol (7%) in people with diabetes mellitus. These guidelines aim to standardise long-term pharmacological treatment to reduce the burden of recurrent stroke in Europe.

L. Bartalena, G. Kahaly, L. Baldeschi et al.

European Journal of Endocrinology • 2021

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD). Choice of treatment should be based on assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for most patients with GO. Risk factors include smoking, thyroid dysfunction, high serum level of thyrotropin receptor antibodies, radioactive iodine (RAI) treatment, and hypercholesterolemia. In mild and active GO, control of risk factors, local treatments and selenium (selenium-deficient areas) are usually sufficient; if RAI treatment is selected to manage GD, low-dose oral prednisone prophylaxis is needed, especially if risk factors coexist. For both active moderate-to-severe and sight threatening GO, antithyroid drugs are preferred when managing Graves' hyperthyroidism. In moderate-to-severe and active GO, intravenous (iv) glucocorticoids are more effective and better tolerated than oral glucocorticoids. Based on current evidence and efficacy/safety profile, costs and reimbursement, drug availability, long-term effectiveness and patient choice after extensive counselling, a combination of iv methylprednisolone and mycophenolate sodium is recommended as first-line treatment. A cumulative dose of 4.5 grams (g) of iv methylprednisolone in 12 weekly infusions is the optimal regimen. Alternatively, higher cumulative doses not exceeding 8 g can be used as monotherapy in most severe cases and constant/inconstant diplopia. Second-line treatments for moderate-to-severe and active GO include: a) a second course of iv methylprednisolone (7.5 g) subsequent to careful ophthalmic and biochemical evaluation, b) oral prednisone/prednisolone combined with either cyclosporine or azathioprine; c) orbital radiotherapy combined with oral or iv glucocorticoids, d) teprotumumab; e) rituximab and f) tocilizumab. Sight threatening GO is treated with several high single doses of iv methylprednisolone per week and, if unresponsive, with urgent orbital decompression. Rehabilitative surgery (orbital decompression, squint and eyelid surgery) is indicated for inactive residual GO manifestations.

Y. Stede, A. Stoicescu, Giusi Amore et al.

EFSA Journal • 2018

Abstract This report of the European Food Safety Authority and the European Centre for Disease Prevention and Control presents the results of zoonoses monitoring activities carried out in 2017 in 37 European countries (28 Member States (MS) and nine non‐MS). Campylobacteriosis was the commonest reported zoonosis and its EU trend for confirmed human cases increasing since 2008 stabilised during 2013–2017. The decreasing EU trend for confirmed human salmonellosis cases since 2008 ended during 2013–2017, and the proportion of human Salmonella Enteritidis cases increased, mostly due to one MS starting to report serotype data. Sixteen MS met all Salmonella reduction targets for poultry, whereas 12 MS failed meeting at least one. The EU flock prevalence of target Salmonella serovars in breeding hens, laying hens, broilers and fattening turkeys decreased or remained stable compared to 2016, and slightly increased in breeding turkeys. Salmonella results on pig carcases and target Salmonella serovar results for poultry from competent authorities tended to be generally higher compared to those from food business operators. The notification rate of human listeriosis further increased in 2017, despite Listeria seldom exceeding the EU food safety limit in ready‐to‐eat food. The decreasing EU trend for confirmed yersiniosis cases since 2008 stabilised during 2013–2017. The number of confirmed shiga toxin‐producing Escherichia coli (STEC) infections in humans was stable. A total of 5,079 food‐borne (including waterborne) outbreaks were reported. Salmonella was the commonest detected agent with S. Enteritidis causing one out of seven outbreaks, followed by other bacteria, bacterial toxins and viruses. The agent was unknown in 37.6% of all outbreaks. Salmonella in eggs and Salmonella in meat and meat products were the highest risk agent/food pairs. The report further summarises trends and sources for bovine tuberculosis, Brucella, Trichinella, Echinococcus, Toxoplasma, rabies, Coxiella burnetii (Q fever), West Nile virus and tularaemia.

E. Berge, W. Whiteley, H. Audebert et al.

European Stroke Journal • 2021

Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide evidence-based recommendations to assist physicians in their clinical decisions with regard to intravenous thrombolysis for acute ischaemic stroke. These guidelines were developed based on the ESO standard operating procedure and followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. The working group identified relevant clinical questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote recommendations. Expert consensus statements were provided if not enough evidence was available to provide recommendations based on the GRADE approach. We found high quality evidence to recommend intravenous thrombolysis with alteplase to improve functional outcome in patients with acute ischemic stroke within 4.5 h after symptom onset. We also found high quality evidence to recommend intravenous thrombolysis with alteplase in patients with acute ischaemic stroke on awakening from sleep, who were last seen well more than 4.5 h earlier, who have MRI DWI-FLAIR mismatch, and for whom mechanical thrombectomy is not planned. These guidelines provide further recommendations regarding patient subgroups, late time windows, imaging selection strategies, relative and absolute contraindications to alteplase, and tenecteplase. Intravenous thrombolysis remains a cornerstone of acute stroke management. Appropriate patient selection and timely treatment are crucial. Further randomized controlled clinical trials are needed to inform clinical decision-making with regard to tenecteplase and the use of intravenous thrombolysis before mechanical thrombectomy in patients with large vessel occlusion.

A. Both Engel, Aziz Cherifi, M. Bechelany et al.

ChemPlusChem • 2015

Invited for this month's cover are collaborating researchers from the DM3 group at the European Membrane Institute of Montpellier, France. The cover picture shows an artistic view of the bioelectrochemical production of sustainable electricity. Laccase enzymes immobilized on aligned electrospun carbon fibers can efficiently reduce dissolved oxygen, and be used in the cathode compartment of an electrical biogenerator. Read the full text of the article at 10.1002/cplu.201402324.

R. Hochstrat, T. Wintgens, P. Corvini

Water Intelligence Online • 2015

The European project MINOTAURUS explored innovative bio-processes to eliminate emerging and classic organic pollutants. These bio-processes are all based on the concept of immobilization of biocatalysts (microorganisms and enzymes) and encompass bioaugmentation, enzyme technology, rhizoremediation with halophytes, and a bioelectrochemical remediation process. The immobilization-based technologies are applied as engineered ex situ treatment systems as well as natural systems in situ for the bioremediation of groundwater, wastewater and soil. The selection and application of tailored physico-chemical, molecularbiological and ecotoxicological monitoring tools combined with a rational understanding of engineering, enzymology and microbial physiology is a pertinent approach to open the black-box of the selected technologies. Reliable process monitoring constitutes the basis for developing and refining biodegradation kinetics models, which in turn improve the predictability of performances to be achieved with technologies. Immobilised Biocatalysts for Bioremediation of Groundwater and Wastewater delivers insight into the concepts and performance of a series of remediation approaches. A key strength of this book is to deliver results from lab-scale through to piloting at different European reference sites. It further suggests frameworks for structuring and making evidence-based decisions for the most appropriate bioremediation measures. This title belongs to European Water Research Series ISBN: 9781780406466 (eBook) ISBN: 9781780406459 (Print)

Mengwei Yuan, Matthew J. Kummer, Shelley D. Minteer

Chemistry – A European Journal • 2019

<jats:title>Abstract</jats:title><jats:p>Atmospheric CO<jats:sub>2</jats:sub> is a cheap and abundant source of carbon for synthetic applications. However, the stability of CO<jats:sub>2</jats:sub> makes its conversion to other carbon compounds difficult and has prompted the extensive development of CO<jats:sub>2</jats:sub> reduction catalysts. Bioelectrocatalysts are generally more selective, highly efficient, can operate under mild conditions, and use electricity as the sole reducing agent. Improving the communication between an electrode and a bioelectrocatalyst remains a significant area of development. Through the examples of CO<jats:sub>2</jats:sub> reduction catalyzed by electroactive enzymes and whole cells, recent advancements in this area are compared and contrasted.</jats:p>

A. Deeke, T. Sleutels, H. Hamelers et al.

Environmental Science &amp; Technology • 2012

We developed an integrated system for storage of renewable electricity in a microbial fuel cell (MFC). The system contained a capacitive electrode that was inserted into the anodic compartment of an MFC to form a capacitive bioanode. This capacitive bioanode was compared with a noncapacitive bioanode on the basis of performance and storage capacity. The performance and storage capacity were investigated during polarization curves and charge-discharge experiments. During polarization curves the capacitive electrode reached a maximum current density of 1.02 ± 0.04 A/m(2), whereas the noncapacitive electrode reached a current density output of only 0.79 ± 0.03 A/m(2). During the charge-discharge experiment with 5 min of charging and 20 min of discharging, the capacitive electrode was able to store a total of 22,831 C/m(2), whereas the noncapacitive electrode was only able to store 12,195 C/m(2). Regarding the charge recovery of each electrode, the capacitive electrode was able to recover 52.9% more charge during each charge-discharge experiment compared with the noncapacitive electrode. The capacitive electrode outperformed the noncapacitive electrode throughout each charge-discharge experiment. With a capacitive electrode it is possible to use the MFC simultaneously for production and storage of renewable electricity.

Xuejie Deng, Yu Li, Hao Liu et al.

Sustainability • 2021

Microbial induced carbonate precipitation (MICP) is a new geotechnical engineering technology used to strengthen soils and other materials. Although it is considered to be environmentally friendly, there is a lack of quantitative data and objective evaluation to support conclusions about its environmental impact. In this paper, the energy consumption and carbon emissions of MICP technology are quantitatively analyzed by using the life cycle assessment (LCA) method. The environmental effects of MICP technology are evaluated from the perspectives of resource consumption and environmental impact. The results show that for each tonne of calcium carbonate produced by MICP technology, 1.8 t standard coal is consumed and 3.4 t CO2 is produced, among which 80.4% of the carbon emissions and 96% of the energy consumption come from raw materials. Comparing using MICP with cement, lime, and sintered brick, the current MICP application process consumes less non-renewable resources but has a greater environmental impact. The major environmental impact that MICP has is the production of smoke and ash, with secondary impacts being global warming, photochemical ozone creation, acidification, and eutrophication. In five potential application scenarios of MICP, including concrete, sintered brick, lime mortar, mine cemented backfill, and foundation reinforcement, the carbon emissions of MICP are 3 to 7 times greater than the emissions of traditional technologies. The energy consumption is 15 to 23 times. Based on the energy consumption and carbon emissions characteristics of MICP technology at the current condition, suggestions are given for the future research of MICP.

C. Manyi-Loh, S. Mamphweli, E. Meyer et al.

International Journal of Environmental Research and Public Health • 2013

With an ever increasing population rate; a vast array of biomass wastes rich in organic and inorganic nutrients as well as pathogenic microorganisms will result from the diversified human, industrial and agricultural activities. Anaerobic digestion is applauded as one of the best ways to properly handle and manage these wastes. Animal wastes have been recognized as suitable substrates for anaerobic digestion process, a natural biological process in which complex organic materials are broken down into simpler molecules in the absence of oxygen by the concerted activities of four sets of metabolically linked microorganisms. This process occurs in an airtight chamber (biodigester) via four stages represented by hydrolytic, acidogenic, acetogenic and methanogenic microorganisms. The microbial population and structure can be identified by the combined use of culture-based, microscopic and molecular techniques. Overall, the process is affected by bio-digester design, operational factors and manure characteristics. The purpose of anaerobic digestion is the production of a renewable energy source (biogas) and an odor free nutrient-rich fertilizer. Conversely, if animal wastes are accidentally found in the environment, it can cause a drastic chain of environmental and public health complications.

Yifan Yu, Jafari Ali, Yuesuo Yang et al.

Energies • 2022

Applying microbial fuel cell (MFC) technology for eco-remediation of Cr(VI) pollution from a subsurface environment has great scientific value and practical significance due to its promising advantages of pollutant remediation and renewable energy generation. The aim of the current review is to summarize the migration characteristics of Cr(VI) in a subsurface soil/water environment and investigate the factors affecting the MFC performance for synchronous Cr(VI) remediation and power generation, and sequentially highlight diverse challenges of MFC technology for in situ remediation of subsurface groundwater and soils. The critical review put forward that Cr(VI) removal efficiency and energy production of MFC can be improved by enhancing the adjustability of cathode pH, setting potential, modifying electrode, and incorporating other technologies into MFC. It was recommended that designing typical large-scale, long-term continuous flow MFC systems, adding electron shuttle media or constructing artificial electron according to actual groundwater/soil and Cr(VI) pollution characteristics, site geology, and the hydrogeology condition (hydrochemical conditions, colloid type, and medium) are essential to overcome the limitations of the small size of the laboratory experiments and improve the application of technology to in situ Cr(VI) remediation. This review provided reference and ideas for future research of MFC-mediated onsite Cr(VI) remediation.

Jafar Ali, Aaqib Sohail, Lei Wang et al.

Energies • 2018

Microbial electrochemical technologies provide sustainable wastewater treatment and energy production. Despite significant improvements in the power output of microbial fuel cells (MFCs), this technology is still far from practical applications. Extracting electrical energy and harvesting valuable products by electroactive bacteria (EAB) in bioelectrochemical systems (BESs) has emerged as an innovative approach to address energy and environmental challenges. Thus, maximizing power output and resource recovery is highly desirable for sustainable systems. Insights into the electrode-microbe interactions may help to optimize the performance of BESs for envisioned applications, and further validation by bioelectrochemical techniques is a prerequisite to completely understand the electro-microbiology. This review summarizes various extracellular electron transfer mechanisms involved in BESs. The significant role of characterization techniques in the advancement of the electro-microbiology field is discussed. Finally, diverse applications of BESs, such as resource recovery, and contributions to the pursuit of a more sustainable society are also highlighted.

Yu-Hsuan Hung, Tzu-Yin Liu, Han‐Yi Chen

ACS Sustainable Chemistry &amp; Engineering • 2019

Microbial fuel cell (MFC) is a sustainable technology that can produce electrons using microbes. However, low power density and high cost are the two major issues that hamper the development of MFCs. In this study, we demonstrated that renewable coffee waste-derived activated carbons (CWACs) can serve as anode materials in Escherichia coli system-based MFCs. By modifying the CWAC pore size, we achieved a power density of 3927 mW m–2, which was higher than that of commercial activated carbon (975 mW m–2). The enhanced power density of the CWAC was attributed to its high conductivity and suitable pore size distribution, which led to fast electron transfer and bacterial adhesion. Furthermore, the long-term performance of the MFC with the CWAC anode was investigated; it continuously functioned for more than 100 h at a power density of 2000 mW m–2 without any further nutrient resupply. These results indicate that CWAC is a promising anode material for renewable and sustainable energy systems that could signifi...

M. Koller

The EuroBiotech Journal • 2023

Abstract Background: Current threats connected to the ongoing depletion of fossil resources and elevated levels of greenhouse gases accelerating climate change and global warming provoke a renaissance of biotechnological production of various organic bulk chemicals, which, particularly during the second half of the 20th century, were almost exclusively produced from fossil resources via chemosynthetic processes. Scope: Besides the manufacture of bioethanol, a product obtained by microbial fermentation, biogenic production of solvents and energy carriers like acetone, isopropanol, 2,3-butanediol, or 1-butanol, hence, processes known since the beginning of the last century, experiences now a substantial revival. Summary of new synthesis and conclusions reached in the review: The review illustrates how to produce these products by resorting to fossil raw materials instead of petrochemical production processes, and how this can be accomplished by the cultivation of anaerobic organisms, namely facultatively anaerobic yeasts and bacteria (production of ethanol or 2,3-butanediol), and strictly anaerobic Clostridia (1-butanol, acetone, or isopropanol) on renewable resources. Moreover, novel methods for producing biodiesel-like methyl-esters of aerobically produced bacterial polyhydroxyalkanoate biopolyester building blocks combine the synthesis of microbial biopolyesters from wastewater with the progress of innovative renewable energy carriers. The biochemical background, the current state of research and development, and the status of industrialization of these processes are reviewed. Conclusion: Challenges to make these bioprocesses, based on inexpensive renewable resources, competitive with or even superior to petrochemical production routes in terms of sustainability, scalability, and economic feasibility still exist: however, they can be overcome by the concerted action of various scientific disciplines.

C. Charcosset

Membranes for Clean and Renewable Power Applications • 2014

Abstract: Membrane processes and renewable energy systems have been extensively developed in recent years to offer a very large range of applications. This chapter gives three examples: renewable energy source used to supply energy to a membrane desalination plant; membrane processes for the production of biofuels and biogas; and a microbial fuel cell which consists of an anode and a cathode chamber separated by a proton exchange membrane. Perspectives, benefits and limitations are discussed.